Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$1.2 - $2.73 $3,018 - $6,865
-2,515 Reduced 0.9%
276,816 $373,000
Q4 2022

Feb 13, 2023

SELL
$1.71 - $3.61 $106,043 - $223,870
-62,014 Reduced 18.17%
279,331 $519,000
Q3 2022

Nov 14, 2022

BUY
$1.9 - $8.63 $628,151 - $2.85 Million
330,606 Added 3078.55%
341,345 $840,000
Q2 2022

Aug 12, 2022

BUY
$2.13 - $9.01 $8 - $36
4 Added 0.04%
10,739 $26,000
Q1 2022

May 13, 2022

SELL
$6.28 - $15.59 $2.06 Million - $5.12 Million
-328,396 Reduced 96.83%
10,735 $86,000
Q4 2021

Feb 10, 2022

BUY
$14.7 - $28.67 $3.29 Million - $6.41 Million
223,536 Added 193.38%
339,131 $5.18 Million
Q3 2021

Nov 10, 2021

BUY
$24.31 - $33.6 $778,916 - $1.08 Million
32,041 Added 38.35%
115,595 $3.29 Million
Q2 2021

Aug 10, 2021

BUY
$26.09 - $40.4 $144,199 - $223,290
5,527 Added 7.08%
83,554 $2.82 Million
Q1 2021

May 10, 2021

BUY
$33.06 - $56.93 $2.04 Million - $3.5 Million
61,556 Added 373.72%
78,027 $2.98 Million
Q4 2020

Feb 10, 2021

SELL
$39.09 - $57.4 $1.74 Million - $2.56 Million
-44,525 Reduced 73.0%
16,471 $689,000
Q3 2020

Nov 13, 2020

BUY
$28.43 - $44.67 $54,699 - $85,945
1,924 Added 3.26%
60,996 $2.64 Million
Q2 2020

Aug 07, 2020

BUY
$11.71 - $30.29 $378,396 - $978,791
32,314 Added 120.76%
59,072 $1.79 Million
Q1 2020

May 15, 2020

SELL
$7.64 - $27.5 $1.53 Million - $5.52 Million
-200,641 Reduced 88.23%
26,758 $366,000
Q4 2019

Feb 10, 2020

SELL
$15.02 - $20.57 $1.08 Million - $1.47 Million
-71,587 Reduced 23.94%
227,399 $3.67 Million
Q3 2019

Nov 14, 2019

BUY
$18.85 - $27.5 $789,438 - $1.15 Million
41,880 Added 16.29%
298,986 $5.76 Million
Q2 2019

Aug 09, 2019

BUY
$17.37 - $26.27 $2.41 Million - $3.65 Million
138,784 Added 117.29%
257,106 $6.04 Million
Q1 2019

May 15, 2019

BUY
$10.65 - $25.75 $1.26 Million - $3.05 Million
118,322 New
118,322 $2.77 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.